Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
FDA mulls upping risk classification of vaginal mesh as lawsuits mount up for big mesh makers
Sep 09 2011
•
By
Madeleine Armstrong
More from Archive
More from Medtech Insight